Sutro Biopharma, Inc. Financial Ratios — STRO Stock

Profitability (USD)

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-35.78	-26.76	-29.38	-11.67	-28.7	-31.86	-24.34	-53.02	-68.12
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	100	100	100	100	100	100	100	100
EBITDA Margin (%)	11.76	-27.6	-85.07	-118.61	-156.27	-151.39	-181.86	-53.64	-372.7	-95.26
Operating Margin (%)	2.28	-37.25	-96.89	-129.79	-166.32	-159.22	-190.26	-58.07	-384.34	-102.41
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	2.85	-38.05	-91.93	-130.44	-74.96	-170.55	-172.2	-57.63	-362.81	-186.55
Profit Margin (%)	2.85	-38.05	-91.93	-130.44	-75.2	-170.55	-175.89	-69.47	-366.62	-186.45
Net Income to Common Margin (%)	- -	-38.05	-91.93	-130.44	-75.2	-170.55	-175.89	-69.47	-366.62	-186.45
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	- -	15	15	10	25	57	50	34	23	16
ST Debt	- -	15	5	1	- -	10	17	10	7	8
LT Debt	- -	- -	10	9	25	47	33	23	16	8
Total Debt/EBITDA	- -	-1.02	-0.45	-0.19	-0.37	-0.61	-0.41	-0.41	-0.1	-0.16
Net Debt/EBITDA	-1.65	0.52	3.38	-0.1	2.72	0.06	0.25	0.79	0.82	0.6
Total Debt/EBIT	- -	-0.76	-0.4	-0.18	-0.35	-0.58	-0.39	-0.38	-0.1	-0.15
Net Debt/EBIT	-8.5	0.39	2.97	-0.09	2.56	0.05	0.24	0.73	0.8	0.55
EBITDA to Interest Expense	- -	-20.73	-20.14	-11.65	-16.8	-29.86	-36.84	-3.47	-7.44	-2.32
EBITDA-CapEx/Interest Expense	- -	-25.54	-21.1	-12.45	-18.59	-34.75	-39.18	-3.65	-7.54	-2.36
EBIT to Interest Expense	- -	-27.97	-22.93	-12.75	-17.88	-31.41	-38.54	-3.76	-7.67	-2.5
Interest Expense	- -	1	2	4	4	3	3	24	31	42
Common Equity/Total Assets	-137.6	-282.1	-67.36	-125.17	-57.81	-97.64	-111.21	-118.82	-203.21	-562.59
Long-Term Debt/Equity (%)	- -	- -	7.6	9.08	7.39	18.59	15.36	15.47	35.14	- -
Long-Term Debt/Capital (%)	- -	- -	-7.38	-4.78	-12.07	-17.02	-8.29	-4.4	-2.05	-0.82
Long-Term Debt/Total Assets (%)	- -	- -	4.48	5.68	6.23	13.76	8.19	4.92	4.05	4.54
Total Debt/Equity (%)	- -	-13.36	11.19	10.1	7.39	22.72	23.23	22.48	51.91	-11.83
Total Debt/Capital (%)	- -	-14.5	-10.86	-5.31	-12.07	-20.79	-12.54	-6.4	-3.03	-1.63
Total Debt/Total Assets (%)	- -	35.72	6.6	6.32	6.23	16.81	12.39	7.15	5.98	9.02
Net Debt to Equity	12.75	6.84	-84.06	5.03	-54.69	-2.1	-14.27	-43.57	-426.68	43.89
Net Debt/Capital (%)	10.84	6.09	42.39	-2.58	44.36	1.73	6.89	10.96	19.95	5.7
EBITDA	7	-14	-33	-51	-67	-94	-123	-82	-231	-98
EBITDA-CapEx	3	-18	-34	-54	-74	-109	-131	-87	-234	-99
Operating Income (Loss)	1	-19	-37	-55	-71	-99	-129	-89	-238	-105

Liquidity (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	0.95	0.69	5.61	3.58	12.44	4.74	5.02	4.01	2.4	1.88
Current Ratio	0.99	0.8	5.76	3.9	12.78	5.24	5.31	4.5	2.6	2.01
Quick Ratio	0.96	0.74	5.68	3.77	12.63	5.04	5.13	4.39	2.47	1.94
CFO/Avg Current Liab	- -	-0.9	0.37	-1.87	-2.17	-2.29	0.07	-1.39	-1.7	-1.71
Common Equity/Total Assets	-137.6	-282.1	-67.36	-125.17	-57.81	-97.64	-111.21	-118.82	-203.21	-562.59
Long-Term Debt/Equity (%)	- -	- -	7.6	9.08	7.39	18.59	15.36	15.47	35.14	- -
Long-Term Debt/Capital (%)	- -	- -	-7.38	-4.78	-12.07	-17.02	-8.29	-4.4	-2.05	-0.82
Long-Term Debt/Total Assets (%)	- -	- -	4.48	5.68	6.23	13.76	8.19	4.92	4.05	4.54
Total Debt/Equity (%)	- -	-13.36	11.19	10.1	7.39	22.72	23.23	22.48	51.91	-11.83
Total Debt/Capital (%)	- -	-14.5	-10.86	-5.31	-12.07	-20.79	-12.54	-6.4	-3.03	-1.63
Total Debt/Total Assets (%)	- -	35.72	6.6	6.32	6.23	16.81	12.39	7.15	5.98	9.02
CFO/Total Liabilities	-8.21	-24.75	13.85	-111	-109.25	-91.94	1.87	-34.76	-55.91	-57.87
CFO/CapEx	-2.99	-11.18	8.15	-18.68	-9.51	-5.33	0.45	-25.87	-61.83	-104.56
Altman's Z-Score	-1.01	-4.43	-0.05	0.67	6.6	3.12	-0.3	-0.65	-3.81	-8.56

Working Capital (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	47.02	18.68	9.73	7.21	6.87	6.92	7.12	2.78	16.28
Days Sales Outstanding	- -	7.76	19.54	37.52	50.65	53.12	52.72	51.28	131.47	22.43
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	52	253	707	686	410	258	142	98
- Cash & Cash Equivalents	12	22	125	5	206	30	47	69	190	58
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	15	15	10	25	57	50	34	23	16
Enterprise Value	-48	-7	-138	145	364	546	126	-84	-151	-27
Total Capital	-95	-100	-136	-186	-203	-276	-402	-526	-764	-962
Total Debt/Capital (%)	- -	-14.5	-10.86	-5.31	-12.07	-20.79	-12.54	-6.4	-3.03	-1.63
Total Debt / EV	- -	-1.95	-0.11	0.07	0.07	0.11	0.4	-0.4	-0.15	-0.57
EV/Sales	- -	- -	- -	3.38	8.51	8.82	1.86	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	18.09	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	8.5	- -	- -	- -
Diluted Market Cap	- -	- -	52	253	707	686	410	258	142	98
Diluted Enterprise Value	-12	-7	-59	257	526	713	413	222	-25	56
EV per Share	- -	- -	- -	62.96	111.62	118.32	24.84	- -	- -	- -
TTM Sales	60	52	38	43	43	62	68	154	62	102
TTM EBITDA	7	-14	-33	-51	-67	-94	-123	-82	-231	-98
TTM Operating Income	1	-19	-37	-55	-71	-99	-129	-89	-238	-105
TTM Cash Flow to Firm	-13	-36	14	-61	-64	-79	7	-83	-160	-135
TTM Free Cash Flow to Firm	-9	-33	16	-57	-57	-63	15	-79	-157	-133

Multiples (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	3.65	-4.1	-11.66	-10.34	35.94	-2.41	-0.76	-0.56
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-48	-7	-138	145	364	546	126	-84	-151	-27
Low Price	- -	- -	85	76.9	60	140.3	33.3	20.05	17	5.23
EV/Sales	- -	- -	- -	3.38	8.51	8.82	1.86	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-1.98	-4.31	-11.7	-8.75	-2.97	-2.65	-1.3	-0.46
Price/Earnings High	- -	- -	-2.59	-5.14	-25.84	-12.37	-6.67	-4.91	-2.09	-0.96
Price/Earnings Low	- -	- -	-1.39	-3.17	-6.08	-6.13	-1.42	-1.13	-0.58	-0.23
Price/Book Value	- -	- -	-0.35	-1.29	-3.1	-2.06	-0.91	-0.46	-0.18	-0.1
Price/Book Value Average	- -	- -	-0.47	-1.23	-1.65	-2.77	-0.78	-0.51	-0.38	-0.09
Price/Book Value High	- -	- -	-0.61	-1.47	-3.64	-3.92	-1.76	-0.94	-0.6	-0.19
Price/Book Value Low	- -	- -	-0.33	-0.9	-0.86	-1.94	-0.37	-0.22	-0.17	-0.05
Price/Tangible Book Value	- -	- -	0.39	2.58	2.13	2.72	1.89	1.72	3.19	-0.74
Price/Tangible Book Value Average	- -	- -	0.53	2.45	1.13	3.65	1.63	1.89	6.64	-0.67
Price/Tangible Book Value High	- -	- -	0.7	2.93	2.5	5.17	3.66	3.51	10.63	-1.38
Price/Tangible Book Value Low	- -	- -	0.37	1.81	0.59	2.56	0.78	0.81	2.95	-0.34
Price/Sales	- -	- -	1.35	5.91	16.55	11.09	6.05	1.68	2.29	0.96
Price/Sales Average	- -	- -	1.82	5.62	8.8	14.92	5.23	1.84	4.77	0.86
Price/Sales High	- -	- -	2.38	6.71	19.43	21.09	11.73	3.41	7.64	1.78
Price/Sales Low	- -	- -	1.27	4.13	4.57	10.46	2.49	0.78	2.12	0.43
Price/Cash Flow	- -	- -	4.1	-3.88	-10.43	-8.4	115.52	-2.31	-0.74	-0.55
Price/Cash Flow Average	- -	- -	5.52	-3.69	-5.55	-11.3	99.84	-2.54	-1.55	-0.5
Price/Cash Flow High	- -	- -	7.22	-4.41	-12.25	-15.98	224.03	-4.7	-2.48	-1.03
Price/Cash Flow Low	- -	- -	3.86	-2.72	-2.88	-7.92	47.61	-1.08	-0.69	-0.25
Price/Free Cash Flow Average	- -	- -	4.92	-3.9	-6.2	-13.91	31.06	-2.64	-1.57	-0.5
Price/Free Cash Flow High	- -	- -	6.43	-4.66	-13.68	-19.67	69.7	-4.89	-2.52	-1.04
Price/Free Cash Flow Low	- -	- -	3.44	-2.87	-3.22	-9.75	14.81	-1.12	-0.7	-0.25
EV/Sales Average	- -	- -	- -	5.73	4.55	15.35	5.28	1.61	2.08	0.45
EV/Sales High	- -	- -	- -	6.82	15.18	21.53	11.78	3.18	4.95	1.37
EV/Sales Low	- -	- -	- -	4.25	0.32	10.89	2.54	0.55	- -	0.02
EV/EBITDA Average	-1.65	0.52	1.24	-4.83	-2.91	-10.14	-2.9	-3	-0.56	-0.47
EV/EBITDA High	-1.65	0.52	0.58	-5.75	-9.72	-14.22	-6.48	-5.93	-1.33	-1.44
EV/EBITDA Low	-1.65	0.52	1.89	-3.58	-0.21	-7.19	-1.4	-1.03	0.15	-0.02
EV/EBIT Average	-8.5	0.39	1.09	-4.42	-2.74	-9.64	-2.77	-2.77	-0.54	-0.44
EV/EBIT High	-8.5	0.39	0.51	-5.26	-9.13	-13.52	-6.19	-5.48	-1.29	-1.34
EV/EBIT Low	-8.5	0.39	1.66	-3.27	-0.19	-6.84	-1.33	-0.95	0.15	-0.02
Last Price	- -	- -	90.2	110	217.1	148.8	80.8	42.9	18.4	11.57
High Price	- -	- -	159	124.9	254.9	283	156.7	87.2	61.3	21.5
Enterprise Value Average	-12	-7	-41	245	194	950	358	247	129	46
Enterprise Value High	-12	-7	-19	292	649	1,332	798	489	307	140
Enterprise Value Low	-12	-7	-62	181	14	674	172	85	-36	2

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	2	2	2	2	5	5	6	6	8	9
Diluted Weighted Avg Shares	1	1	1	2	3	5	5	6	8	8
Basic Weighted Avg Shares	1	1	1	2	3	5	5	6	8	8
Revenue per Share	85.36	73.94	66.71	18.61	13.12	13.42	13.36	25.55	8.02	12.06
EBITDA per Share	10.04	-20.41	-56.75	-22.08	-20.5	-20.31	-24.29	-13.71	-29.89	-11.49
Operating Income per Share	1.95	-27.54	-64.64	-24.16	-21.81	-21.36	-25.41	-14.84	-30.82	-12.35
Basic EPS, GAAP	- -	-28.14	-61.33	-24.28	-9.86	-22.88	-23.49	-17.75	-29.4	-22.49
Basic EPS from Cont Ops	2.43	-28.14	-61.33	-24.28	-9.86	-22.88	-23.49	-17.75	-29.4	-22.49
Diluted EPS, GAAP	- -	-28.14	-61.33	-24.28	-9.86	-22.88	-23.49	-17.75	-29.4	-22.49
Diluted EPS from Cont Ops	2.43	-28.14	-61.33	-24.28	-9.86	-22.88	-23.49	-17.75	-29.4	-22.49
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-18.8	-52.98	22.02	-28.32	-20.82	-17.71	0.7	-18.55	-24.76	-20.86
Free Cash Flow per Basic Share	-25.08	-57.72	19.32	-29.84	-23	-21.03	-0.85	-19.27	-25.16	-21.06
Cash & Equivalents per Share	67.91	31.47	355.09	51.34	113.02	42.92	65.9	62.43	40.96	16.64
Book Value per Share	-136.23	-164.36	-261	-85.25	-69.94	-72.28	-89.19	-92.97	-101.7	-115.08
Tangible Book Value per Share	-129.91	-155.77	228.41	42.59	101.94	54.76	42.78	24.87	5.76	-15.59

Sutro Biopharma, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)